Odetiglucan Clinical Trials

2 actively recruiting trials across 1 location

Filter by location:

Philadelphia, Pennsylvania2 trials

Maintenance Combinatorial Myeloid Immunotherapy for Unresectable Pancreatic Cancer

Hospital of the University of Pennsylvania

Phase 2

Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma

Abramson Cancer Center at the University of Pennsylvania

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.